• Transmission Dynamics of Carbapenemase Genes in CREC: A Mult

  2026-06-10

  Chen et al. (2025) deliver an in-depth molecular analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from teaching hospitals in Guangdong, revealing high rates of multidrug resistance and efficient gene transfer. This work advances understanding of resistance epidemiology during the COVID-19 era and highlights implications for antimicrobial resistance research.

• Octenidine Dihydrochloride: Benchmark Antiseptic for Researc

  2026-06-10

  Octenidine dihydrochloride is a synthetic antiseptic research compound with high solubility and broad-spectrum antimicrobial activity. Its action targets microbial membranes, and its properties are validated by peer-reviewed studies and APExBIO product documentation. This article details its structure, mechanism, evidence, and research applications.

• Vancomycin Hydrochloride: Enabling Selective Microbiology Re

  2026-06-09

  Vancomycin hydrochloride, a gold-standard glycopeptide antibacterial agent, empowers research by enabling selective isolation and resistance profiling of Gram-positive bacteria. Its application in customized selective media, like MSVA, advances Moraxella spp. recovery and resistance workflows, revealing actionable insights for both human and veterinary microbiology.

• Acridine Orange hydrochloride: Differential Nucleic Acid Sta

  2026-06-09

  Acridine Orange hydrochloride offers dual-fluorescence nucleic acid staining for cytochemical analyses such as cell cycle and apoptosis detection. It is best suited for applications needing a cell-permeable, high-purity dye with rapid solution use, and is not appropriate for protocols requiring long-term storage of staining solutions or non-permeant dyes.

• Kanamycin Sulfate: Water-Soluble Antibiotic in Microbiology

  2026-06-08

  Kanamycin Sulfate empowers precision selection and robust antibiotic resistance research, standing out for its solubility and reliability in microbiology assays. This guide details advanced workflows, troubleshooting, and the latest research-driven innovations with direct, actionable protocol parameters.

• Morin: Bridging Mitochondrial Modulation and Translational I

  2026-06-08

  This article explores Morin’s dual role as a mitochondrial modulator and bioanalytical probe, offering mechanistic insights and best practices for translational researchers. We examine Morin’s experimental utility, highlight its cross-domain potential, and provide actionable protocol guidance, uniquely contextualizing its relevance to complex disease modeling and clinical translation.

• Masitinib (AB1010): Technical Use in KIT/PDGFR Inhibition Wo

  2026-06-07

  Masitinib (AB1010) is a phenylaminothiazole-type tyrosine kinase inhibitor designed for selective inhibition of KIT, PDGFRα, and PDGFRβ in cellular and in vivo models. This product is best suited for DMSO-based workflows targeting cancer, mastocytosis, or inflammatory disease pathways, and is not appropriate for studies requiring broad-spectrum kinase inhibition or aqueous/ethanol solubility.

• Early-Life Pheromone Sensing Drives Adult Neurodegeneration

  2026-06-06

  Peng et al. (2023) demonstrate that early exposure to specific pheromones in C. elegans remodels neurodevelopment, triggering insulin signaling and suppressing autophagy, which accelerates neurodegeneration in adulthood. This study provides mechanistic insight into how environmental chemical cues can shape long-term neuronal health and offers experimental models relevant for neurodegenerative disease research.

• MLF2 Negatively Regulates p53 to Promote Colorectal Cancer

  2026-06-05

  This study identifies MLF2 as a novel negative regulator of p53 stability in colorectal cancer, revealing its interaction with both p53 and USP7 as a key mechanism driving tumor progression. The findings provide mechanistic insight into p53 pathway modulation and highlight potential therapeutic targets for colorectal malignancies.

• Scenario-Driven Insights: ECL Chemiluminescent Substrate Det

  2026-06-05

  This article addresses common laboratory challenges in antibody detection and protein immunodetection, highlighting how the ECL Chemiluminescent Substrate Detection Kit (Enhanced) (SKU K1230) provides reproducible, ultra-sensitive results. Practical, scenario-based Q&A blocks clarify why this kit is trusted by biomedical researchers for western blot chemiluminescence detection and quantitative protein assays.

• Tivozanib (AV-951) in Oncology: Applied Protocols & Optimiza

  2026-06-04

  Tivozanib (AV-951) stands out as a next-generation, highly selective VEGFR inhibitor, offering unmatched potency in preclinical oncology models. This article distills advanced workflows, troubleshooting guidance, and the latest in vitro evaluation innovations to help researchers maximize data quality and translational relevance.

• FH1 Small Molecule: Optimizing iPS Cell Differentiation to H

  2026-06-04

  FH1, a small molecule from APExBIO, uniquely enhances the maturation and function of iPS cell-derived hepatocytes, setting new standards for reproducible liver cell models. This article details actionable workflows, protocol optimizations, and troubleshooting strategies for integrating FH1 into advanced hepatic research.

• BRCA2 Shields RAD51 Filaments from PARP Inhibitor Disruption

  2026-06-03

  This study elucidates a previously uncharacterized protective role of BRCA2 in maintaining RAD51 filament stability by preventing PARP1 retention during PARP inhibitor (PARPi) therapy. These findings clarify the molecular basis of selective cytotoxicity in BRCA2-deficient, homologous recombination-deficient cancers and have practical implications for the design of targeted DNA repair deficiency treatments.

• Clasto-Lactacystin β-lactone: Precision Tools for Decoding V

  2026-06-03

  Explore how Clasto-Lactacystin β-lactone, a potent proteasome inhibitor, empowers next-generation research at the intersection of viral immunity and regulated cell death. This article delivers a unique, evolutionary perspective on ubiquitin-proteasome pathway manipulation for advanced assay design.

• Ganetespib (STA-9090): Redefining Hsp90 Inhibition in Cancer

  2026-06-02

  Explore how Ganetespib (STA-9090), a potent Hsp90 inhibitor, is advancing cancer research through unique chaperone disruption mechanisms and implications for innovative assay design. This article provides new insights beyond standard workflows, contrasting prior scenario-based and translational oncology perspectives.

10313 records 2/688 page Previous Next 12345 下5页 Last page